28.2.2021
Patients can digitally record benefits and side effects
Munich-based startup XO Life has developed a platform that allows patients to digitally record their treatment progress.
The Munich-based start-up XO Life (formerly Medikura) has developed an innovative digital platform that revolutionizes the monitoring of drug effectiveness and safety. The “ImpactMonitor” enables patients to digitally document treatment processes and relevant side effects. This data, including quality of life information, is systematically collected, pseudonymized and prepared for pharmaceutical companies and research institutes. They can use the data to improve pharmacovigilance and meet legal requirements.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
XO Life News
Discover even more news
medac and XO Life implement cooperation for digital therapy support in uro-oncology
medac and XO Life have developed innovative digital product and therapy support for one of the most important urological medac products.
XO Life is among the top 5% of the top-rated companies on kununu
XO Life uses an outstanding team culture, remote work and team spirit to be one of the highest rated startups on kununu.
XO Life: From German Startup to Pioneer Across Europe
XO Life stands out as a digital pioneer by supporting precision medicine through the use of patient-reported results.